The Future of Regenerative Medicine
Celltex Therapeutics is a Houston-based biotechnology company specializing in banking one’s own mesenchymal stem cells, often called MSCs, for therapeutic use.
Celltex’s proprietary stem cell processing and banking methods ensure the genetic integrity and uniformity of an individual’s cells in quantities never before possible and in the quantities necessary for therapeutic applications. An individual can then use his or her banked stem cells for regenerative therapy through infusions or injections performed by a licensed physician in Cancun.
Celltex Therapeutics Corporation was founded in 2011 by David Eller and Dr. Stanley Jones, a nationally known spine surgeon, to spearhead breakthroughs in regenerative medicine through Mesenchymal Stem Cells (MSCs). Celltex uses proprietary technology that isolates, multiplies and stores autologous, adult, adipose (fat tissue)-derived MSCs to be used for regenerative therapy in a number of conditions, including vascular, autoimmune and degenerative diseases.
Today, Celltex Therapeutics Corporation remains committed to leading the United States into the future of regenerative medicine through adult stem cells. Its industry leadership and visionary approach continue to drive the company to improve the quality of life of thousands of individuals, with a concerted focus to make this therapy accessible to all in the near future.